(Q64139686)
Statements
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Center Study of Eculizumab in Patients With Generalized Myasthenia Gravis (gMG) Who Have Moderate to Severe Muscle Weakness Despite Treatment With Immunosuppressants (English)
0 references
October 2008
0 references
March 2011
0 references
14
0 references
18 year
0 references
80 year
0 references